Long-term sequelae of adverse pregnancy outcomes
Related Experiment Video
Updated: Sep 5, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Nare Torosyan1, Dalia Aziz2, Odayme Quesada3
1Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, United States of America.
Insights
Adverse pregnancy outcomes (APOs) like hypertensive disorders of pregnancy and gestational diabetes increase long-term cardiovascular disease (CVD) risk. Recognizing APOs is crucial for women's cardiovascular risk assessment and prevention strategies.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Public Health
Background:
- Adverse pregnancy outcomes (APOs) are increasingly recognized as significant indicators of future cardiovascular disease (CVD) risk in women.
- Current cardiovascular risk stratification often overlooks the long-term cardiovascular implications of pregnancy complications.
Purpose of the Study:
- To conduct a comprehensive review of the long-term cardiovascular consequences associated with various APOs.
- To emphasize the importance of incorporating APOs into women's cardiovascular disease risk assessment.
Main Methods:
- Systematic literature review utilizing electronic databases, including PubMed and the Cochrane Library.
- Analysis of studies examining the association between APOs (hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, low birth weight, fetal growth restriction) and subsequent CVD.
Main Results:
- Women experiencing APOs, particularly hypertensive disorders of pregnancy, preterm birth, and low birth weight, face a higher risk of developing CVD post-pregnancy.
- Hypertensive disorders of pregnancy and gestational diabetes are identified as independent risk factors for atherosclerotic CVD, especially in women with multiple APOs.
- The pathophysiology linking APOs to CVD is multifactorial, involving both physiological and environmental elements.
Conclusions:
- Adverse pregnancy outcomes significantly elevate a woman's lifetime risk for cardiovascular disease.
- APOs, including hypertensive disorders of pregnancy and gestational diabetes, should be integrated into routine cardiovascular risk assessment and stratification protocols for women.
- Further research is warranted to elucidate the precise mechanisms underlying the increased CVD risk following APOs.
Abstract:
A growing body of literature highlights the importance of recognizing adverse pregnancy outcomes (APOs) as cardiovascular risk factors when risk stratifying women for cardiovascular disease (CVD). We conducted a comprehensive review of the long term cardiovascular consequences associated with APOs including hypertensive disorders of pregnancy (HDP), preterm delivery, gestational diabetes (GDM), low birth weight and fetal growth restriction during pregnancy using electronic databases, PubMed and the Cochrane Library. Women with pregnancies complicated by HDP, preterm birth, and low birth weight are at higher risk of developing CVD than were women without APOs in the years following pregnancy. Among women with a history of multiple APOs, HDP and GDM are independent risk factors for atherosclerotic CVD. The pathophysiology leading to CVD is multifactorial, and includes both physiologic and environmental factors. APOs should be accounted for in a women's CVD risk assessment and stratification as recommended by prevention guidelines. Further research is needed to determine the underlying mechanisms that lead to the increased risk of CVD in women with APOs.
Related Concept Videos
Teratogenicity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Mitral Valve Prolapse III: Nursing Management
Asthma-III: Symptoms and Complications
Classification of Asthma
Ovarian Cycle

